Astrazeneca AZN
NYSE AZN
$159.18 +0.57 (+0.36%)
At close: Oct 9, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Profit After Tax (2009 - 2026)

Updated

Astrazeneca (AZN) reported Profit After Tax of $3.09 billion for Q2 2026, down 18.8% from $3.81 billion a year earlier and down 34.9% from the prior quarter.

Analysis

Astrazeneca (AZN) Profit After Tax (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Astrazeneca's Profit After Tax came in at $25.89 billion, up 120.5% year-over-year; for FY2025, it came in at $14.57 billion, up 40.9% from FY2024.

  • Profit After Tax has increased for three consecutive years, with a five-year compound annual growth rate of 25.5% (FY2020 to FY2025).
  • By year, Profit After Tax came in at $10.34 billion in FY2024 (+30.9%), $7.9 billion in FY2023 (+362.2%), $1.71 billion in FY2022 and -$645 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Profit After Tax since Q4 2024.
  • Year over year, Profit After Tax gained in seven of the last eight quarters, with growth averaging 116.5%.
  • The high point for year-over-year Profit After Tax in five years was Q3 2023 (growth of 853.5%); the low point was Q2 2022 (a decline of 86.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $4.75 billion (Q1 2026), $14.1 billion (Q4 2025) and $3.95 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 5.53 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 3.62 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 5.28 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 3.09 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -10.50 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn -246.00 Mn
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.09 Bn
Mar 31, 2026 4.75 Bn
Dec 31, 2025 2.63 Bn
Sep 30, 2025 3.95 Bn
Jun 30, 2025 3.81 Bn
Mar 31, 2025 3.88 Bn
Dec 31, 2024 1.83 Bn
Sep 30, 2024 2.22 Bn
Jun 30, 2024 2.87 Bn
Mar 31, 2024 3.42 Bn
Dec 31, 2023 835.00 Mn
Sep 30, 2023 1.93 Bn
Jun 30, 2023 2.36 Bn
Mar 31, 2023 2.72 Bn
Dec 31, 2022 654.00 Mn
Sep 30, 2022 202.00 Mn
Jun 30, 2022 134.00 Mn
Mar 31, 2022 718.00 Mn
Dec 31, 2021 -926.00 Mn
Sep 30, 2021 -2.35 Bn
API Access

Astrazeneca Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=AZN&period=max&api_key=YOUR_API_KEY